Evidence map›Paper›PMID 37186014›Full record

ArticleNeuro-oncology2023

Mitogen-induced defective mitosis transforms neural progenitor cells.

Hiba K Omairi, Cameron J Grisdale, Mathieu Meode, Alexandra K Bohm, Sophie Black, Nancy J Adam, Cassidy P Chapman, Tatiana Maroilley, John J Kelly, Maja Tarailo-Graovac and 3 more

Open access · greenAbstract read
In one paragraph

Article in Neuro-oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hiba K OmairiArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Cameron J GrisdaleCanada's Michael Smith Genome Sciences Centre and BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Mathieu MeodeArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Alexandra K BohmArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Sophie BlackArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Nancy J AdamArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Cassidy P ChapmanArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Tatiana MaroilleyBiochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
John J KellyArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Maja Tarailo-GraovacBiochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
Steven J M JonesCanada's Michael Smith Genome Sciences Centre and BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Michael D BloughArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
John Gregory CairncrossArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-5169-5039
University of Calgary · CAUniversity of British Columbia · CA

Funding

CIHR
6 · The paper itself

Abstract

backgroundChromosome instability (CIN) with recurrent copy number alterations is a feature of many solid tumors, including glioblastoma (GBM), yet the genes that regulate cell division are rarely mutated in cancers. Here, we show that the brain-abundant mitogen, platelet-derived growth factor-A (PDGFA) fails to induce the expression of kinetochore and spindle assembly checkpoint genes leading to defective mitosis in neural progenitor cells (NPCs).

methodsUsing a recently reported in vitro model of the initiation of high-grade gliomas from murine NPCs, we investigated the immediate effects of PDGFA exposure on the nuclear and mitotic phenotypes and patterns of gene and protein expression in NPCs, a putative GBM cell of origin.

resultsNPCs divided abnormally in defined media containing PDGFA with P53-dependent effects. In wild-type cells, defective mitosis was associated with P53 activation and cell death, but in some null cells, defective mitosis was tolerated. Surviving cells had unstable genomes and proliferated in the presence of PDGFA accumulating random and clonal chromosomal rearrangements. The outcome of this process was a population of tumorigenic NPCs with recurrent gains and losses of chromosomal regions that were syntenic to those recurrently gained and lost in human GBM. By stimulating proliferation without setting the stage for successful mitosis, PDGFA-transformed NPCs lacking P53 function.

conclusionsOur work describes a mechanism of transformation of NPCs by a brain-associated mitogen, raising the possibility that the unique genomic architecture of GBM is an adaptation to defective mitosis that ensures the survival of affected cells.

Indexed as

GlioblastomaNeural Stem CellsAnimalsHumansMiceMitogensMitosisTumor Suppressor Protein p53MitogensTumor Suppressor Protein p53GBMkinetochoremitosisP53PDGFA

Identifiers

PMID37186014
PMCPMC10547526
OpenAlexW4367184303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.